Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis

Table 1

Baseline characteristics of the study participants.

Number of patients	20
Age, median years (range)	31 (18–60)
Male, n (%)	6 (30)
SCCAI, median (IQR)	8 (4)
CRP, median (IQR)	4.0 (12)
Hb, median (IQR)	13.0 (1.2)
Ferritin, median (IQR)	43 (58)
Platelets, median (IQR)	328 (193)
Baseline fecal calprotectin, median μg/g (IQR)	1801 (1453)
Montreal classification, n (%)
Left-sided colitis	10 (50)
Extensive colitis	10 (50)
Mayo endoscopic subscore, n (%)
1	2 (10)
2	9 (45)
3	9 (45)
Medical treatment, n (%)
5-ASA	20 (100)
Prednisolone	1 (5)
Thiopurine	4 (20)
Methotrexate	1 (5)
Anti-TNF	3 (15)

SCCAI: Simple Clinical Colitis Activity Index; IQR: interquartile range; CRP: c-reactive protein; Hb: haemoglobin.